Resmed has continued to be a great investment for the Australian investor with the AUD staying below 80c, meaning that the ASX listing is now flirting with all-time-highs. This has given a skeptical investor like me some time to see how the Bright Tree acquision pieces together as part of the overall strategy.
Thus far I haven't been able to justify the hefty purchase, but the combined strength of the underlying industry and Resmeds cash cow core business has provided me with some time to sit patiently.
Ann: ResMed Announces Results for the Third Quarter of FY 2017, page-8
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$37.28 |
Change
0.200(0.54%) |
Mkt cap ! $22.38B | |||
| Open | High | Low | Value | Volume |
| $37.50 | $37.55 | $37.15 | $17.93M | 480.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3363 | $37.27 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.30 | 1001 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| RMD (ASX) Chart |
